Search

Alnylam Pharmaceuticals Inc

Fermé

SecteurSoins de santé

281.86 0.64

Résumé

Variation du prix de l'action

24h

Actuel

Min

279

Max

288.78

Chiffres clés

By Trading Economics

Revenu

20M

206M

Ventes

70M

1.2B

P/E

Moyenne du Secteur

78.851

60.549

BPA

1.99

Marge bénéficiaire

17.649

Employés

2,500

EBITDA

159M

304M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+60.8% upside

Dividendes

By Acuity

Prochains Résultats

30 juil. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

631M

42B

Ouverture précédente

281.22

Clôture précédente

281.86

Sentiment de l'Actualité

By Acuity

50%

50%

176 / 342 Classement par Healthcare

Alnylam Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 juil. 2026, 23:41 UTC

Correlated Moves
News
Macro News
ETF Constituents

Vanguard Information Technology ETF declined in after-market hours amid rising crude oil prices and negative sentiment from Oracle's losses, impacting major tech stocks.

13 juil. 2026, 23:26 UTC

News

Shares of Netflix are higher in after-market hours as options traders make bullish bets ahead of the earnings report on July 16.

13 juil. 2026, 23:16 UTC

News

Marriott International will release second-quarter 2026 earnings on August 3, 2026. Shares are higher in after-hours trading, though near the lower end of their range.

13 juil. 2026, 23:11 UTC

News

USD/THB is advancing in Monday's session, supported by a recovery from earlier lows. Rising inflation concerns are influencing market dynamics ahead of upcoming reports.

13 juil. 2026, 23:06 UTC

Social Media
News

Biogen received FDA approval for LEQEMBI IQLIK, a subcutaneous Alzheimer's treatment, boosting shares modestly higher in after-market trading.

13 juil. 2026, 22:51 UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, influenced by rising crude oil prices and concerns over inflation and interest rates.

13 juil. 2026, 22:51 UTC

News

The USD/ZAR is trading higher amid geopolitical tensions following U.S. strikes against Iran, maintaining strength near its one-month range.

13 juil. 2026, 22:31 UTC

News
ETF Constituents

Vanguard Growth ETF trades higher in after-market hours, supported by Nvidia and Texas Instruments, amid rising crude oil prices and inflation concerns.

13 juil. 2026, 22:31 UTC

News
Correlated Moves

iShares 7-10 Year Treasury Bond ETF rises slightly after market close, amid rising crude oil prices and inflation concerns influencing broader market volatility.

13 juil. 2026, 22:21 UTC

News

Vanguard Total Bond Market ETF is modestly higher in after-market trading as crude oil prices rise amid escalating U.S.-Iran military tensions.

13 juil. 2026, 22:01 UTC

News

The USD/HUF is gaining, reaching a session high as rising oil prices heighten inflation concerns and potential Federal Reserve interest rate hikes.

13 juil. 2026, 21:51 UTC

Correlated Moves
News

The iShares 20+ Year Treasury Bond ETF is slightly higher in after-market trading as rising U.S. Treasury yields follow President Trump's Iranian blockade announcement.

13 juil. 2026, 20:21 UTC

Correlated Moves
News
ETF Constituents

The Russell 2000 Index is modestly lower after-market, reflecting broader market declines amid U.S.-Iran tensions. Vanguard Small-Cap ETF remains little changed.

13 juil. 2026, 20:07 UTC

Social Media
News

American Airlines Group shares are lower amid concerns over high debt and disappointing revenue passenger miles, despite some optimistic social media discussions.

13 juil. 2026, 20:07 UTC

News
Correlated Moves

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The cryptocurrency fell from an earlier session high.

13 juil. 2026, 20:07 UTC

Correlated Moves
News

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The asset remains above its 20-day moving average.

13 juil. 2026, 20:07 UTC

News
Correlated Moves
Social Media

The Polish zloty has weakened, contributing to a modest rise in USD/PLN since Friday's close amid increased military tensions and inflation concerns.

13 juil. 2026, 20:07 UTC

News
Correlated Moves

Silver/NZD declines amid rising inflation concerns linked to surging crude oil prices and fears of interest rate hikes. The asset has closed lower for three sessions.

13 juil. 2026, 20:07 UTC

Correlated Moves
News

Silver is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions. The asset has pulled back from earlier session gains.

13 juil. 2026, 20:07 UTC

News
Correlated Moves

Silver Ounce vs Euro is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions, marking three consecutive sessions lower.

13 juil. 2026, 20:07 UTC

Correlated Moves
News

Silver declines amid rising inflation concerns and crude oil price surge. The asset has pulled back from earlier gains, continuing a downward trend.

13 juil. 2026, 20:07 UTC

News
Correlated Moves

Silver declines amid rising inflation concerns linked to crude oil prices. The asset has pulled back from earlier gains and remains below its 20-day moving average.

13 juil. 2026, 20:07 UTC

News
Correlated Moves

USD/CZK is trading higher, supported by broader gains and approaching the upper end of its one-month range amid inflation data and Federal Reserve policy focus.

13 juil. 2026, 20:07 UTC

News
Correlated Moves

The US Dollar Index's rise supports USD/DKK, which is higher since Friday's close. Concerns over U.S.-Iran military actions impact market sentiment.

13 juil. 2026, 20:06 UTC

News

Fiserv shares are higher as leadership changes prompt analysts to monitor potential impacts. The company is also considering the sale of its STAR payment network.

13 juil. 2026, 20:06 UTC

News
Social Media

MercadoLibre opens a new distribution center in Nuevo León, Mexico, creating over 2,000 jobs and enhancing logistics amid rising e-commerce demand. Shares are higher.

13 juil. 2026, 20:06 UTC

News

Gold is trading higher, supported by inflation concerns linked to rising crude oil prices amid U.S.-Iran tensions. Silver has declined after earlier gains.

13 juil. 2026, 20:06 UTC

Correlated Moves
News

The USD/SGD is trading higher, reflecting strength near its one-month range. Broader market dynamics and geopolitical tensions are influencing currency movements.

13 juil. 2026, 20:06 UTC

Correlated Moves
News

The USD/SEK is trading higher, influenced by broader currency market movements and concerns over supply disruptions in the Strait of Hormuz.

13 juil. 2026, 20:06 UTC

News
Correlated Moves

Silver/JPY is declining amid rising inflation concerns linked to crude oil prices and escalating U.S.-Iran tensions. The asset has traded lower for three consecutive sessions.

Comparaison

Variation de prix

Alnylam Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

60.8% hausse

Prévisions sur 12 Mois

Moyen 463.19 USD  60.8%

Haut 550 USD

Bas 400 USD

Basé sur 20 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

20 ratings

19

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

176 / 342Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat